Abstract: Screening of non-typhoidal Salmonella enterica clinical isolates (n=20) by PCR revealed the high prevalence of class 1 integrons (45%). Multidrug-resistant (MDR) phenotypes were observed in all integron-positive isolates, regardless of the serotype. A significant correlation was found between the MDR phenotype and the presence of class 1 integrons in the isolates, especially in S. Typhimurium.
INTRODUCTION
Multidrug-resistant (MDR) Salmonella enterica strains are considered as a significant threat to human health in both developed and developing countries. Association between class 1 integrons and MDR has been established for a number of S. eneterica serotypes [1] [2] [3] [4] [5] . Surveillance and epidemiological studies demonstrated a considerable geographic variation in the prevalence and types of integrons among clinical isolates [1, 2, 4, 5] . However, there is a lack of information on the occurrence of class 1 integrons in Salmonella isolates in Armenia. Thus the aim of the present work was to investigate the prevalence of class 1 integrons and their relationship with the susceptibility to antibiotics in non-typhoidal Salmonella clinical isolates at this location.
MATERIALS AND METHODS

Isolates
The study included a collection of 20 non-typhoidal Salmonella enterica subsp. enterica strains isolated in 2011 from the patients at the "Nork" Clinical Hospital of Infectious Diseases (Yerevan, Armenia). Diagnosis was based on clinical presentations and laboratory analyses. Clinical presentations consistent with gastroenteritis were diarrhea, fever, nausea, vomiting, and abdominal cramps. Anamnesis of food consumed, *Address correspondence to this author at the Institute of Molecular Biology of National Academy of Sciences of RA, 7 Hasratyan St., 0014, Yerevan, Republic of Armenia; E-mail: linazakharyan@gmail.com water sources, social gatherings, anybody else with a similar illness, and any recent history of travel was also recorded. For this investigation, only the patients that were not taking any type of medication including antibiotics before the hospital admission were chosen. Fecal samples were collected on the first or the second day of hospital admission. All the strains isolated from fecal samples confirmed to be Salmonella enterica by standard biochemical and serological tests. Biochemical tests for the identification of Salmonella were fermentation of glucose, negative urease reaction, lysine decarboxylase, negative indole test, H 2 S production, and fermentation of galactitol (dulcitol). Serotypes of Salmonella were determined using the standard Kauffman-White scheme with the use of commercially available polyvalent antisera for flagellar (H) and for lipopolysaccharide (O) antigens.
For detoxification and rehydration, all patients were subjected to the standard infusion therapy. Based on the severity of the disease, 86% were placed on antibiotic therapy: (i) 38% received intravenous or intramuscular ceftriaxone (50mg/kg/day); (ii) 42% received peroral ciprofloxacin (0.5-1.0 g/day); and (iii) the rest were on the combination of one of the two drugs and trimethoprim/sulfamethoxazole. All study subjects (or parent/guardian if a child), gave their written consent to give fecal samples for the study. The study protocol was approved by the Ethics Committee of the Institute of Molecular Biology NAS RA (IORG number 0003427, Assurance number FWA00015042, and IRB number 00004079).
Antibiotic (AB) Susceptibility Tests
The isolates were tested for the susceptibility to eight classes of antibiotics by disc diffusion. Standard disk diffusion method was used according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) [6] . The disks used (Micromaster Laboratories Pvt. Ltd., INDIA) contained ten antibiotics: streptomycin (S), gentamicin (G), amoxicillin/clavulanic acid (Au), ceftriaxone (Cx), trimethoprim/sulfamethoxazole (Tm/S), sulfisoxazole (Su), ampicillin (A), chloramphenicol (C), ciprofloxacin (Cp), and tetracycline (T). The isolates were classified as susceptible, intermediately resistant or fully resistant according to the CLSI guidelines [7] .
Detection of Class 1 Integrons
Total DNA of isolates for PCR-amplification was prepared with the use of the FastDNA Kit (Qbiogene, Inc.), according to the manufacturer`s protocols. All strains were tested for the presence of class 1 integrase-specific intI1 gene, variable segment of integrons, and 3`-conserved segment. Primers, PCR mix composition and PCR conditions used were as described previously [5] . PCR products were visualized by ethidium bromide staining after gel electrophoresis using 1.2% agarose.
RESULTS
Among 20 Salmonella clinical isolates tested nine isolates demonstrated the presence of intI1 ( Table 1) . PCR-amplification with the set of primers for 3`-conserved segment indicated that all intI1 + strains produce the amplicons of the expected size (800bp) and thus were positive for the 3`-conserved segment too. The remaining Salmonella isolates did not generate PCR amplicons with any of the primer sets 
Resistance profile Number of AM classes used ( Table 1 ) and, therefore, they were considered as integron-negative (intI1 -).
Thus, the results showed the presence of class 1 integrons in 45% of the isolates (9 out of 20), five of which were identified as S. Typhimurium (55.6%), three isolates were identified as S. Enteritidis (33.3%), and one strain belonged to another Salmonella serotype ( Table 1) .
PCR-amplification with the set of primers targeting the variable segment of integrons indicated the putative gene cassettes in all intI1 + strains ( Table 1 , Figure 1) since there were no "empty" integrons among them. All variable segments were represented by a single amplicon, and these amplicons were represented by two types: (i) those producing a 1000 bp amplicon (5 isolates: 3 -S. Enteritidis, 1 -S. Typhimurium, and 1 -other Salmonella), and (ii) those producing an amplicon of about 1500 bp (4 isolates, all S. Typhimurium).
All Salmonella clinical isolates were tested for the susceptibility to ten antibiotics. The highest level of susceptibility among the isolates tested was registered towards ciprofloxacin and gentamicin (95%). Resistance profiles and the number of antibiotic classes to which bacterial isolates were simultaneously resistant are summarized in Table 1 mentioned penta-resistance profile are located in complex class 1 integrons, named In104, within 3´ end of the chromosomal genomic island SGI1 [1, 8] . SGI1 is an integrative mobilizable element (IME), which can be transferred horizontally to other serotypes [9, 10] . The different types of SGI1 MDR complex integrons have been described in a wide variety of S. enterica serotypes [11] [12] [13] 18 ].
Noticeably, four of the remaining S. Typhimurium isolates with the MDR phenotype exhibited the same resistance profile to seven classes of antibiotics, ACSSuTAuCx (isolates 17-20). It is known as another important MDR phenotype of non-typhoidal Salmonella [14] . This profile includes resistance to amoxicillin/clavulanic acid (Au) and ceftriaxone (Cx) in addition to the penta-resistance profile of S. Typhimurium phage type DT104.
Conspicuously, all MDR S. Typhimurium isolates were intI1 + while the remaining S. Typhimurium isolates were resistant to no more than two classes of antibiotics and all of them were intI1 -. Thus, the strong association between MDR phenotype and the presence of class 1 integrons in the S. Typhimurium isolates was observed.
Among the ten S. Enteritidis isolates tested, four (40%) were resistant at least to four antibiotic classes thus exhibiting an MDR phenotype. Moreover, three of them (isolates [12] [13] [14] exhibited the profiles of resistance to six antibiotic classes, closely resembling the aforementioned penta-resistance profile, typical of S. Typhimurium DT104. The differences were observed in resistance to one antibiotic ( 
DISCUSSION
In this work we focused on the prevalence of class 1 integrons and comparative analysis of resistance profiles between integron-positive and integronnegative isolates. Screening of Salmonella clinical isolates (n=20) detected the high prevalence of class 1 integrons (45%) with the two types of embedded gene cassettes of about 1000 bp (predominantly in S. Enteritidis) and 1500 bp (S. Typhimurium only), occurring separately. In general antibiotic resistance profiles displayed certain serotype-specific features. Our results revealed that 25% of the isolates tested exhibited MDR phenotypes typical of non-typhoidal Salmonella, either with penta-resistance, ACSSuT, as in S. Typhimurium DT104, or resistance to 7 (ACSSuTAuCx) antibiotics [14] . It is of note that the latter isolates were S. Typhimurium, which is of great concern. Notably, among the S. Enteritidis isolates tested this MDR phenotype was not detected, although the closely related resistance patterns were observed. Although the resistance level in S. Enteritidis isolates is not as high as in S. Typhimurium, the MDR phenotype has become increasingly common in S. Enteritidis, which may compromise the therapy.
CONCLUSIONS
Thus, the results indicated the high prevalence of class 1 integrons and associated MDR among the clinical Salmonella enterica isolates in Armenia, which may complicate the choice of antibiotics for empirical therapy. Further studies are necessary to reveal the genetic background of MDR phenotypes and to estimate the genetic kinship among the isolates. More rigorous regulations should be imposed on antibiotic use, together with a vigilant epidemiological surveillance, to prevent the emergence and spread of MDR non-typhoidal Salmonella isolates.
